chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began with generalized itching.  Hives on arms and legs noted 1/8/2010.  Called MD.  Went to ER 1/8/10 to 1/9/10.  Treated with prednisone, Benadryl and Claritin.  Medications to be completed 1/15/2010
"Softball" sized swelling at injection site, 2 days after injection given per physician's office.
Rash covering entire body starting morning after shot given, itchy. Treatment Prednisone & BENADRYL at night & SOLUMEDROL shot.
Patient developed myocarditis with acute chest pain and peak troponin of 11. He required 2 nights of hospitalization. He symptomatically improved within 48 hours with troponin trending down to 6. He had normal echo.
minor chills; body ache; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jan2021 17:00 (Lot number: EL3247) at the age of 51 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19,, Prev dose brand=Pfizer,, Prev dose brand unknown=False,, Prev dose lot number=EK9231,, Prev dose lot unknown=False,, Prev dose administration date=09Jan2021,, Prev dose administration time=02:00PM, Prev dose dose number=1,, Prev dose vaccine location=Left arm), administration date: 09Jan2021, when the patient was 51 years old, for Covid-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 07Dec2021 20:00, outcome "recovered", described as "minor chills"; PAIN (non-serious) with onset 07Dec2021 20:00, outcome "recovered", described as "body ache"; HEADACHE (non-serious) with onset 07Dec2021 20:00, outcome "recovered", described as "headache". Therapeutic measures were not taken as a result of chills, pain, headache.  Additional information: The patient did not receive any other vaccine within four weeks of vaccination. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies.  No follow-up attempts are possible. No further information is expected.
Bilateral shots led to bilateral cellulitis with central erythema and induration. Red area about 1 1/2 cm indurated area about 4cm.
pains/other pain; muscle aches; Headache; Arm pain; Fatigue; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills). On 20-Jan-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN (pains/other pain) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.
Got vaccines 9-17-18. Patient said she spiked a fever 9-18. Next morning (today 9-19), her upper right arm (deltoid) was red, swollen, and she said she's in pain. Tried ibuprofen, acetaminophen. Tried diphenhydramine cream, even though there was no itching. She is heading to urgent care/clinic.
Dizziness, Headache, Myalgia, Fever, Chills Narrative:
Information has been received from a medical assistant (also reported as a healthcare worker) referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 20-JAN-2017 the patient was inadvertently vaccinated with a fourth dose of RECOMBIVAX HB injection (dose, route, site of administration, lot # and expiration date were not reported) for prophylaxis (extra dose administered). No adverse effects were reported. Product quality complaint was not involved. Additional information has been requested.
drowsiness;lump on this vax site;fever;loss of appetite;crying frequently;started p/vax & still occasionally;
Persistent cough with light mucus (5 weeks) Symptoms still persistent at time of this reporting.
Information has been received from a woman in a medical office concerning a 27 month old female patient with no allergies and no past medical history who on 2/5/03 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (lot # 640556/0258M). Concomitant vaccination on 2/5/03 included a third IM dose in the left arm of HIB conjugate vaccine. Concomitant vaccination on 2/24/03 included a first SC dose in the right arm of MMR (lot # 641722/0127M) and a fourth IM dose in the left arm of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine (lot # 491193). There was no illness at the time of vaccination. On 2/11/04, the patient developed chicken pox. Medical attention was not sought. Subsequently, the patient recovered. The reporter also mentioned five other patients who developed chicken pox post vaccination with varicella virus vaccine live (WAES0407USA00539, 0407USA00540, 0407USA00542, 0407USA00544, and 0407USA00548). Additional information is not expected.
This case was reported by a health professional and described the occurrence of a swollen arm in a 4 year old male pt who received Infanrix. On 8/9/04, the pt received the 5th dose of Infanrix in the left arm. On 8/9/04, the pt also received injections of Varivax, in the right leg and IPOL in the right arm. Approximately 1 day after the administration of Infanrix, 8/10/04, the pt experienced swelling of the "whole left arm" and an injection site reaction of the left arm characterized as a painful "softball-sized rash with raised hives that is 4 inches long and 3 inches wide". The pt was seen at a physician's office and was treated with Zyrtec and ice. The event resolved on 8/13/04. The health professional considered the events to probably be related to vaccination with Infanrix.
This spontaneous report was received from an unspecified healthcare professional concerning an unspecified number of patients of unknown age and gender. Since an unknown date between September 2012 and November 2012, patients were vaccinated with the doses of improperly stored (exposed for 123 hours at 46 Fahrenheit) VARIVAX (Merck) (lot number and expiry date reported as 670554/0672AA and 05-MAY-2013 respectively, dose and route unspecified). No concomitant medications were reported. No adverse effects were reported. This is one of the several reports from the same source. Additional information has been requested.
Patient received vaccine in afternoon, the following morning he woke up with a  droopy face.  Doctor diagnosed him with Bell Palsy.
3/23/2021 The patient developed LLQ pain without radiation.. Aggravating factors: activity, pressure and anything that increases pressure to this area - specifically taking deep breaths in and out; bending over to tie shoes; or twisting toward the left side that patient can recall.  Alleviating factors: lying back. Associated symptoms: NONE. The patient denies anorexia, belching, chills, constipation, diarrhea, dysuria, fever, flatus, frequency, headache, hematuria, myalgias, nausea and vomiting. Denies unexplained weight changes.  Patient denies epigastric pain. Denies hx of GI issues in the past. Denies new medications or recent exposure to contaminated food/drinks. She denies taking OTC medications for pain.  Last bowel movement last night and reports this was normal, soft brown color.
Patient called the pharmacy after visiting her doctor to report that her arm was red, hot, itchy and swollen from the site of the injection down to the bend at her elbow. She had the reaction start within a few hours of the injection. She has been taking benadryl and using ice.
Had a sore hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (unknown if pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown), for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "Had a sore hand". It was unknown if therapeutic measures were taken as a result of pain in extremity.  Additional Information: It was unknown if other vaccine in four weeks was administered. It was unknown if patient had covid prior to vaccination and if covid tested post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Injection site very sore. Malaise, fever, dizziness, immediately following injections. 24-25 hrs later, he fainted, fell and hit his chin and neck on stairs. 3 inch laceration (lower rt jawline) and 2 multiple abrasions on neck (lower rt jawline) and left side of face.
arm is tender; feel like they have at temperature; Head is hurting; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (arm is tender), FEELING ABNORMAL (feel like they have at temperature) and HEADACHE (Head is hurting) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced TENDERNESS (arm is tender), FEELING ABNORMAL (feel like they have at temperature) and HEADACHE (Head is hurting). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, TENDERNESS (arm is tender), FEELING ABNORMAL (feel like they have at temperature) and HEADACHE (Head is hurting) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided.
Dramatic changes in vision (fluctuating focus, headaches, needing to change power of reading glasses frequently throughout the day)
Had a large local reaction with pain and swelling.  Woke up with shaking all over and nausea without vomiting.  Felt "drunk" and woozy 11/02 and called in sick.  Was "woozy" for 2 days and then that resolved.  Still feels shaky in hands but getting better one week later.  No leg weakness or numbness.
By Saturday 3pm Dec 4th. I sought out Emergency room .I had been feeling a numbed sensation in my legs and muscles and or veins throbbed throughout my body, heart was throbbing along with my neck, confusion with thoughts, at times hard to breathe in and out. Not painful just unsteady with walking
1-5-09 pm notices red spots on back of neck and a lot on stomach. 1-16-09 8AM when woke up this AM, red spots were all over face, back, neck and some on stomach. Dr. appt 2:15 pm - Diagnosis was vaccine reaction to MMR vaccine, no fever, not painful and will go away on their own, no treatment required.
Dizziness, Myalgia, NauseaVomiting, shaking, chills, sweats, "tunnel vision but did not pass out." Narrative:  Myalgia, nausea, dizzy, shaking, chills, sweats, "tunnel vision but did not pass out."
please note: vaccine was administered at a pharmacy and I do not have access to the lot number patient presented to the clinic on 5/7/2021 with fatigue and a circular area of induration on left arm approx 6cm in diameter. area was red, slightly tender and warm
Immediately after I administered the vaccine, the patient passed out. He fell onto the floor and  we witnessed some oral seizure like type movement . The patient was unconscious for approximately  1.5-2 minutes.  Our Chief Medical Officer was on site and walking into the room as the patient fell. We immediately placed him on his left side, protected his head, and stayed with him.  We called 911 immediately due to the uncertainty of health issues. Once conscious, the patient explained to us that he experiences such every time he receives a vaccine. He was assessed by the CMO as well as the EMTs that arrived on scene.  His vitals were taken. He was moved into a comfortable position and monitored.  He was alert and orientated x 3.  We requested he have someone pick him up instead of him driving himself home which he did.  This gentleman is also an employee and we were able to see him and verify all was well in the following days. We also recommended he tell all vaccinators that he experiences  LOC post vaccination. When he receives his second dose  we plan to have him lying down and our CMO will be present.  We recommended he follow-up with his PCP.
This spontaneous report was received from a vaccine coordinator (non-health care professional) and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medication and drug reactions or allergies was reported. On unknown dates in 2016, the patient were vaccinated with improperly stored doses of M-M-R II lot # L020189, expiration date 03-JUN-2017 and lot # L007578 expiration date 05-MAR-2017 (dose, route of administration and anatomical location were not provided). The vaccines were refrigerated and exposed to the following temperature and time frames out of range: 1 Celsius degree for 165 hours between 01-JUL-2016 and 07-JUL-2016, 1 Celsius degree for 126.75 hours between 14-JUL-2016 and 19-JUL-2016, -2 Celsius degrees 70.5 hours between 22-JUL-2016 and 25-JUL-2016, 1 Celsius degree for 191.5 hours between 28-JUL-2016 and 05-AUG-2016, 1 Celsius degree for 77 hours between 06-AUG-2016 and 09-AUG-2016, 1 Celsius degree for 166 hours between 12-AUG-2016 and 18-AUG-2016, 10 Celsius degrees for 79.5 hours between 19-AUG-2016 and 22-AUG-2016, 9 Celsius degrees for 22 hours between 23-AUG-2016 and 24-AUG-2016, 1 Celsius degree for 71 hours between 26-AUG-2016 and 29-AUG-2016, 1 Celsius degree for 53 hours between 30-AUG-2016 and 31-AUG-2016, 0 Celsius degree for 168 hours between 15-SEP-2016 and 21-SEP-2016, 0 Celsius degrees for 218 hours between 22-SEP-2016 and 30 SEP-2016 and 1 Celsius degree for 92 hours between 01-OCT-2016 and 05-OCT-2016 (summary time of excursions 1500.25 hours). There were no adverse effects reported.  There were no data logger and no prior excursions. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a non health care professional referring to unspecified number of patients of unknown age and gender. Patients' pertinent medical history, drug reactions/allergies or concomitant information was not reported. On 03-OCT-2016, the patients were vaccinated with improperly stored doses of VARIVAX lot # L032391, expiration date: 26-AUG-2017 (strength, dose and route of administration were not provided). No adverse events were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pt's mother & grandmother brought child to PH office to show nursing staff dried, cracked hands & feet (peeling). They had been to provider week before to show very swollen extremities which occurred approximately 1 wk after receiving 6 shots at their office. Pt's MD said it was likely a reaction to Varicella vaccine.
This spontaneous report was received from a physician via field employee, refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were unspecified by reporter. On an unknown date, the patient was vaccinated with ZOSTAVAX vial 19400 plaque-forming unit (PFU), 19400 PFU/once. On an unknown date, the patient developed the shingles 8 months after being administered ZOSTAVAX. The outcome of the event was unknown. Causality assessment was not provided. The patient sought medical attention (spoke to her neive). No product quality complaint (PQC) was involved. No further adverse event information was provided. Additional information has been requested.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 27-OCT-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 2.5 ml/five dose vial, lot # K007773 and expiration date 01-MAY-2015 (administration route was not provided). No adverse effects were reported. The vaccine had one temperature excursion of 48 hours with a lowest recorded temperature of 1 Fahrenheit (F) (1 Celsius (C)). The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
I was diagnosed with Covid-19; arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She also admitted diagnosed with COVID-19 in October 2020) in October 2020.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site). At the time of the report, COVID-19 (I was diagnosed with Covid-19) and VACCINATION SITE PAIN (arm is sore at the injection site) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, SARS-CoV-2 test: positive (Positive) she was diagnosed with COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Outcome of event updated. Patient reported she was fine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event (vaccination site pain), a causal relationship cannot be excluded.
Muscle aches, Joint pain (all), Chills, fever, Headache, Extreme fatigue, lightheadedness, complete loss of appetite. Localized pain and redness at Bilateral injection sites.  All symptoms lasted 48 hours
The vial was initially stored in the refrigerator on 31-May-2022 and the dose was administered on 01-Jul-2022; Moderna vaccine administered beyond 30 day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-May-2022 and the dose was administered on 01-Jul-2022) in a 66-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 054A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered beyond 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-May-2022 and the dose was administered on 01-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-May-2022 and the dose was administered on 01-Jul-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored from freezer to refrigerator on 31-May-2022 at 4 PM. The vaccine was administered on 01-Jul-2022 between 9 AM to 12 noon. The vial did not undergo any temperature excursions. it was reported that the days were miscalculated.  No treatment medications were reported.
Patient woke up with trouble breathing around 4 in the morning. Patient's spouse gave her Benadryl and symptoms resolved. Patient then experienced a slight fever and spouse gave her ibuprofen. Afterwards patient experience a swollen eye, red, itch and watery. She did not go to a doctor office or hospital. Symptoms continued into the 30th and patient was told to go to eye doctor and do another dose of Benadryl.
Numb and slightly tingling upper lip (as if affected by Novocain).  Lower forehead was slightly numb at the surface level.  Arm that received shot had more pain than ever felt from a flu shot. Later that afternoon the numbness, then decreased moved to the the lower lip.
Pt. presented approximately 3 hours after injecting FLUVIRIN and PNEUMOVAX 23 in same arm. Pt. was experiencing redness/swelling/pain at injection site. Was referred to local ED for examination. Patient was given diphenhydramine at pharmacy.